Scott Bizily, Chief Legal Officer at 4D Molecular Therapeutics, Inc. (FDMT), sold 3,270 shares at $12.00 ($40K) on 2026-08-13, disclosed to the SEC on 2026-08-17.
Scheduled sale ($40k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.00 | 1,635 | $20K | 49.6% |
| 2 | $12.20 | 1,635 | $20K | 50.4% |
| Total | $12.10 avg | 3,270 | $40K | 100% |
| Filing → |
| FDMT | SELL | 2026-07-02 | $92K | — | Filing → |
| FDMT | SELL | 2026-06-25 | $118K | — | Filing → |
| FDMT | SELL | 2025-12-19 | $18K | — | Filing → |